just about a week after it gave the same authorization for a vaccine developed by Pfizer and BioNTech. using messenger RNA technology. In clinical trials, the vaccine was found to be approximately 94.5% effective in protecting people against COVID-19, the disease caused by the novel coronavirus.
The vaccine comes at a time when the US is dealing with a surge in COVID-19 cases. The disease has led to more than 316,000 deaths so far in the US this year, according to data fromWhile the vaccine will not bring an end to the ongoing surge, theit first be distributed among healthcare workers and among people living in long-term care facilities.
On Sunday, Vivek Murthy, who President-elect Joe Biden intends to nominate as US surgeon general, said the current timeline for coronavirus vaccine distribution was optimistic, addingWorkers at a distribution center in Olive Branch, Mississippi, prepared the shipment of the Moderna vaccine supply Sunday.
A worker at McKesson's Olive Branch, Miss. distribution center prepares packed and sealed cooler boxes containing Moderna COVID-19 vaccine doses for shipment.The US Food and Drug Administration authorized Moderna's vaccine for emergency use on Friday. A worker inside the walk-in freezer at McKesson’s Olive Branch, Miss. distribution center adds cold packs into a cooler box of Moderna COVID-19 vaccine doses to maintain their temperature requirements during shipping.
The logo should stretch across the entire box. $MRNA
1) U.S population is 330 million people. 2) Minimal herd immunity of 70% is 231 million people. 3) 2 shot vaccine requires 461 million doses. 4) 1 shot vaccine reqiures 231 million doses. Don't panic. Do the math. Set realistic expectations.
90% of news about covid and trump